News & Updates

A recent study has provided further evidence on the incidence of central nervous system (CNS) coccidioidomycosis, which is a rare and potentially dangerous complication of disseminated coccidioidomycosis. Many patients present with relatively low compliment fixation (CF) titer, and hydrocephalus often occurs.

For children with uncomplicated malaria, early treatment with an ultra-short course of high-dose primaquine is noninferior to delayed treatment at preventing Plasmodium vivax infection, according to a study.

New drug applications approved by US FDA as of 01-15 March 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Individuals who have trouble falling asleep and who use sleep medications are at increased risk of dementia, as reported in a study.

Using methylphenidate and a selective serotonin reuptake inhibitor (SSRI) together does not appear to pose any significant risk, with both agents having been shown to be safe in adolescent patients with attention deficit-hyperactivity disorder (ADHD) and depression, according to a new-user cohort study.